✦ LIBER ✦

Pasireotide: A Review of Its Use in Cushing’s Disease

✍ Scribed by Kate McKeage

Book ID: 120804721
Publisher: Springer International Publishing AG
Year: 2013
Tongue: English
Weight: 421 KB
Volume: 73
Category: Article
ISSN: 0012-6667
DOI: 10.1007/s40265-013-0052-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of hyperglycaemia in Cushing'

Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide

✍ Reznik, Y. (author);Bertherat, J. (author);Borson-Chazot, F. (author);Brue, T. ( 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 799 KB

Management of hyperglycaemia in Cushing'

Management of hyperglycaemia in Cushing's disease: Experts’ proposals on the use of pasireotide

✍ Reznik, Y. (author);Bertherat, J. (author);Borson-Chazot, F. (author);Brue, T. ( 📂 Article 📅 2013 🏛 Masson Editeur 🌐 French ⚖ 799 KB

A 12-Month Phase 3 Study of Pasireotide

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

✍ Colao, Annamaria; Petersenn, Stephan; Newell-Price, John; Findling, James W.; Gu 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 707 KB

Salivary cortisol is a useful tool to as

Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing’s disease

✍ Trementino, Laura; Cardinaletti, Marina; Concettoni, Carolina; Marcelli, Giorgia 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 318 KB

Extended treatment of Cushing’s disease

Extended treatment of Cushing’s disease with pasireotide: results from a 2-year, Phase II study

✍ Boscaro, M.; Bertherat, J.; Findling, J.; Fleseriu, M.; Atkinson, A. B.; Peterse 📂 Article 📅 2013 🏛 Springer US 🌐 English ⚖ 205 KB

Significant response to pasireotide (SOM

Significant response to pasireotide (SOM230) in the treatment of a patient with persistent, refractory Cushing's disease

✍ Kimberly Cukier; Reena Tewari; Fabian Kurth; Herbert A. Schmid; Clinton Lai; Dav 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 873 KB